Announced Thu, 2 Jul · 17:59 IST
Postal Ballot: RPT approvals, loan limit hike, IPO fund reallocation
Board & Shareholder Meetings View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹1335.50
prior close
₹1350.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.6-0.6+0.3+1.3+2.1+6.7+6.2+5.9+9.3+3.9———
Up moveDown movePending
AI summary
Senores Pharma postal ballot seeks approval on 8 resolutions. Key items include material related party transactions worth about Rs 754 crore with subsidiaries Havix, Ratnatris, and Apnar Pharma for FY27. Also proposes raising loan and investment limits to Rs 750 crore each, and reallocating Rs 650.16 million of IPO proceeds from the Atlanta sterile injections project to other subsidiary projects. E-voting: July 5 to August 3, 2026.
Likely market impact
Shareholders should review large RPTs with group companies and the IPO fund reallocation from Atlanta sterile injections project; e-voting ends August 3.